Home » FDA Clears Gynesonics’ Sonata System for Treating Uterine Fibroids
FDA Clears Gynesonics’ Sonata System for Treating Uterine Fibroids
The FDA granted 510(k) approval for Gynesonics’ Sonata system, a sonography-guided transcervical fibroid ablation device.
The device uses intrauterine ultrasound technology with a radiofrequency ablation device to treat uterine fibroids.
The Sonata system provides women with a transcervical treatment for uterine fibroids that requires no incisions.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May